Global Surgical Site Infection Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Surgical Site Infection Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

A surgical site infection is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only. Other surgical site infections are more serious and can involve tissues under the skin, organs, or implanted material.

Market Overview:

The latest research study on the global Surgical Site Infection market finds that the global Surgical Site Infection market reached a value of USD 4742.24 million in 2022. It’s expected that the market will achieve USD 6472.14 million by 2028, exhibiting a CAGR of 5.32% during the forecast period.

Opportunities

In the future, the manufacturers tend to increase research and development efforts, apply for certification in different regions, improve its productivity and create competitive advantage, offering high performance product at a cost-effective price point. For example, based on characteristics of different types of surgery, the production of products specifically for a certain type of surgery. For some patients with low resistance, produce more anti-infective products.
For example, China, India, South America, have large population in the world, with the progress of economy, development of local enterprises, the market of Surgical Site Infection has great market potential in those Regions.
As the world's medical standards continue to increase, the number of operations is also rising, especially in developing regions. Demand for Surgical Site Infection products has increased in some regions in recent years. In particular, government regulations in some regions have contributed significantly to the industry.
M&A and strategic cooperation within the Surgical Site Infection industry have resulted in technical exchanges between different suppliers, and some of Surgical Site Infection's products are highly technical and co-developed to reduce the cost of each supplier. And technical exchange can promote technological progress in the industry, improve product standards, and regulate the market.

Region Overview:

North America had the highest growth rate of all regions.

Company Overview:

Stryker Corporation is one of the major players operating in the Surgical Site Infection market, holding a share of 15.93% in 2018.

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Paul Hartmann AG, a medical device company, manufactures and sells medical and hygiene products for wound care, incontinence, disinfection, and surgical efficiency in Europe, America, Africa, Asia, and Oceania. The company offers wound management solutions comprising traditional and modern wound dressings; bandages for compression therapy, and immobilization; treatment sets for various applications; and Vivano, a negative-pressure wound therapy system, as well as first aid kits and diagnostic products, such as clinical thermometers and blood pressure monitors. It also provides absorbent products, such as briefs, pads, and pants.

Segmentation Overview:

Among different product types, Intraoperative Phase segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Surgical Site Infection market covered in Chapter 3:

Getinge Group
B. Braun Melsungen AG
Lac-Mac Limited
Covalon Technologies Ltd.
Belimed AG
CareFusion Coporation (Becton, Dickinson and Company)
Paul Hartmann AG
SSIP, LLC
Johnson & Johnson
Steris PLC
3M Company
Medtronic Plc
Ansell Limited
Stryker Corporation

In Chapter 4 and Chapter 14.2, on the basis of types, the Surgical Site Infection market from 2018 to 2029 is primarily split into:

Intraoperative Phase
Preoperative Phase
Postoperative Phase

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Surgical Site Infection market from 2018 to 2029 covers:

Hospitals
Ambulatory Surgical Centers (ASCs)
Clinics
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)